You've got Mail!
Well, you really don't want to get this letter from the FDA. The title of the web page says it all:
FDA 483 letters are public records and can be viewed by anyone.
We have reviewed the 2nd quarter 2016 FDA 483 letters issued and see some trends in calibration that you should avoid.
Issuing offices include New York, Baltimore, Kansas City, Dallas, Philadelphia, New jers and, Seattle.
While public records, letters were redacted to remove company names and processes.